Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide to prevent intradialytic hypotension in maintenance hemodialysis
ChiCTR2000039724Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of furosemide in end-stage kidney disease (ESKD) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Rate of symptomatic intradialytic hypotension. Planned start Jun 2019; status: not yet recruiting.
02
Drugs
furosemide
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ChiCTR2000039724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039724.